Macrogenics Inc (MGNX)
4.295
-0.20
(-4.56%)
USD |
NASDAQ |
Jun 25, 16:00
4.33
+0.04
(+0.81%)
Pre-Market: 08:46
Macrogenics Gross Profit (TTM): 34.99M for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 34.99M |
December 31, 2023 | 48.97M |
September 30, 2023 | 109.36M |
June 30, 2023 | 140.91M |
March 31, 2023 | 152.55M |
December 31, 2022 | 142.21M |
September 30, 2022 | 84.22M |
Date | Value |
---|---|
June 30, 2022 | 59.62M |
March 31, 2022 | 66.75M |
December 31, 2021 | 72.18M |
September 30, 2021 | 112.53M |
June 30, 2021 | 115.95M |
March 31, 2021 | 100.85M |
December 31, 2020 | 97.76M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
34.99M
Minimum
Mar 2024
152.55M
Maximum
Mar 2023
95.63M
Average
99.31M
Median
Gross Profit (TTM) Benchmarks
Moderna Inc | 1.086B |
Allurion Technologies Inc | 37.23M |
Novavax Inc | 424.85M |
Viking Therapeutics Inc | -- |
Verrica Pharmaceuticals Inc | 7.097M |